The 3D cell culture market is witnessing a noteworthy progression owing to growing demand for organ transplantation, increasing investment by major players and increased research related activities.
New York, NY -- (SBWIRE) -- 09/05/2017 -- 3D cell culture brings up a process of developing cell culture in a 3D environment. Its advanced cell culture technique overcomes restrictions of the 2D cell culture by the way of cellular features and actions. The requirement for developing a cell culture technique which can precisely trigger proliferation, normal cell morphology, migrations, and differentiation. Influence of drug doses can be studied efficiently parallel to conservative 2D cell culture, as cells grow more accurately in the former.
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/3329
In addition, 3D cell culture's competence to substitute the animal in research and pharmaceutical testing is also fuelling market growth.
Several research groups and top market companies are investing in 3D cell culture, stimulating the market for 3D cell culture technique on a universal level. Over the forecast period 2014-2020, the global 3D cell culture market is anticipated to grow up to US$ 2,717.6 Mn by the end of 2020 and the market is projected at a strong CAGR of 29.1%.
Some of the major companies contending in the universal market for 3D cell culture technique consists of Becton Dickinson and Company, Thermo Fisher Scientific, Inc., Corning Incorporated, and Sigma-Aldrich Corporation. Along with other notable players like 3D Biotek LLC, Reinnervate Ltd, Global Cell Solutions, Inc., Biomatrix, Inc., InSphero AG and Lonza Group.
The market is classified on the basis of end-user, technology, and application. Based on end-user, the market is divided into four categories - hospitals and diagnostic centers, research laboratories and institutes, biotechnology and pharmaceutical industries and others. Biotechnology and pharmaceutical industries are forecasted to stay foremost over the period.
Browse Complete Report @ https://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp
By technology, the market is further divided into five sub-segments – gels, bioreactors, extracellular matrices or scaffolds, scaffold-free platforms, and microchips. Scaffolds are estimated to be the top sub-segment, however, microchips are likely to see the fastest growth by 2020-end.
On the basis of application, the market is divided into clinical applications, drug discovery, research, tissue engineering and stem cell biology. The estimated leading sub-division is drug discovery.
Hospitals, research institutes and laboratories, biotechnology entities and pharma companies are progressively adopting this technique for improved results. The use of laboratory automation for culturing 3D cells has become one of the popular trends in the market.
Request to view table of content @ https://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market/toc
However, the small and medium sized laboratories and pharmaceutical companies may face a financial challenge, as the preliminary investment related to the application of 3D cell culture is costly. Additionally, the products of 3D cell culture technique, in general, lacks reliability that is another aspect that could slow up their demand over the forecast period.
Based on the regional analysis, Europe is projected to be the biggest market followed by the UK along with Asia and the rest of the world during 2014-2020. The global 3D cell culture market is segmented into four key regions - North America, Europe, Asia and Rest of the world.